Kelly A. Plummer is a technical specialist with Marshall, Gerstein & Borun working with the biotechnology and chemical practice groups.
Most recently, Dr. Plummer served as a postdoctoral researcher at Bayer HealthCare Pharmaceuticals in the Systems Biology Department where she directed all project activities toward discovery and validation of novel drug targets for oncology indications.
Dr. Plummer received her Ph.D. in Chemistry and Chemical Biology from Harvard University. She holds a B.S. in Chemistry (with high distinction) and a B.S. in Mathematics, magna cum laude, from the University of Minnesota.
Publications
Plummer, K.A., Kohler, A.C., Parry, G., Bringmann, P. & Larsen, B.R., “Activity of the Ubiquitin C-terminal Hydrolase UCH-L1 is Upregulated in the DU145 Prostate Cancer Cell Line,” manuscript in preparation
Plummer, K.A., Kohler, A.C., Parry, G., Bringmann, P. & Larsen, B.R., “Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Activity is Upregulated in the DU145 Prostate Cancer Cell Line” (poster) Ubiquitin & Signaling Keystone Symposium, Big Sky, Montana, (2007)
Plummer, K.A., Carothers, J.M., Yoshimura, M., Szostak, J.W. & Verdine, G.L., “In Vitro Selection of RNA Aptamers Against a Composite Small Molecule-Protein Surface,” Nucleic Acids Res., 33, 5602-5610 (2005)
Brezin, E., Byrne, R., Levy, J., Pilgrim, K. & Plummer, K., “A Census of Rational Maps,” Conform. Geom. Dyn. 4, 35-74 (2000)
Plummer, K.A. & Forsyth, C.J., "Comprehensive Investigation of the Okadaic Acid Pharmacophore" (poster) Beckman Scholars Symposium, Irvine, California, (1999)
NOTEWORTHY
- National Defense Science and Engineering Graduate (NDSEG) Fellowship
- Beckman Scholars Award for Research in Chemistry and Biological Sciences